Dear colleagues.

This eBook, "Pharmacotherapeutics of Polycystic Ovary Syndrome (PCOS)," provides an in-depth overview of the pharmacotherapeutic landscape in managing Polycystic Ovary Syndrome (PCOS). The eBook covers various topics related to PCOS, such as its definition, pathology, and management. The authors conducted a thorough search using various databases, including Medline, Embase, CENTRAL, Web of Science, Scopus, and Google Scholar, to gather relevant evidence on PCOS. PCOS is a complex endocrine disorder affecting women of reproductive age, characterized by symptoms such as irregular menstrual cycles, hyperandrogenism, and polycystic ovaries. Pharmacotherapy plays a crucial role in managing PCOS, aiming to alleviate symptoms, restore hormonal balance, and mitigate long-term health risks such as infertility, cardiovascular disease, and metabolic dysfunction. The eBook delves into the multifaceted pharmacotherapeutic approaches employed in PCOS management, including surgical treatment, hormonal therapies, insulin-sensitizing agents, anti-androgens, and emerging novel treatments. It elucidates the mechanisms of action, efficacy, and safety profiles of various pharmacotherapeutic agents used in PCOS management and provides insights into personalized treatment strategies tailored to address the heterogeneous manifestations of PCOS. The eBook discusses the evolving landscape of PCOS pharmacotherapy, highlighting recent advancements, ongoing clinical trials, and potential future directions in drug development. With contributions from leading experts, this comprehensive resource serves as a valuable resource for clinicians, researchers, and healthcare professionals involved in the care of women with PCOS, offering evidence-based guidance and fostering a deeper understanding of pharmacotherapeutic approaches aimed at optimizing patient outcomes and improving quality of life. The eBook consists of 11 chapters, each containing multiple sections. In total, there are 139 Multiple-Choice Questions (MACQs) along with their corresponding Guiding Answers.